339 related articles for article (PubMed ID: 11840450)
1. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
Cherin P; Pelletier S; Teixeira A; Laforet P; Genereau T; Simon A; Maisonobe T; Eymard B; Herson S
Arthritis Rheum; 2002 Feb; 46(2):467-74. PubMed ID: 11840450
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P
Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
[TBL] [Abstract][Full Text] [Related]
3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
Nakamura H; Fujikawa K; Kawakami A; Tamai M; Yamasaki S; Ida H; Eguchi K
Mod Rheumatol; 2010 Oct; 20(5):496-9. PubMed ID: 20383652
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
Chérin P; Herson S
Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
Cherin P
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
[TBL] [Abstract][Full Text] [Related]
9. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
Illa I
J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G
Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756
[TBL] [Abstract][Full Text] [Related]
11. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
Chérin P; Herson S
Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Beghi E; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Macchia R; Cavaletti G; Giannini F; Sabatelli M;
Lancet Neurol; 2012 Jun; 11(6):493-502. PubMed ID: 22578914
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Choy EH; Hoogendijk JE; Lecky B; Winer JB
Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
Wang DX; Shu XM; Tian XL; Chen F; Zu N; Ma L; Wang GC
Clin Rheumatol; 2012 May; 31(5):801-6. PubMed ID: 22274797
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin therapy for refractory myositis.
Moriguchi M; Suzuki T; Tateishi M; Hara M; Kashiwazaki S
Intern Med; 1996 Aug; 35(8):663-7. PubMed ID: 8894745
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
[TBL] [Abstract][Full Text] [Related]
19. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ
Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients.
Dobloug C; Walle-Hansen R; Gran JT; Molberg Ø
Clin Exp Rheumatol; 2012; 30(6):838-42. PubMed ID: 22935197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
